Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Clinic of Rheumatology, Orthopaedics Traumatology and Reconstructive Surgery, Institute of Clinical Medicine, Faculty of Medicine, Vilnius University, 03101 Vilnius, Lithuania.
Medicina (Kaunas). 2024 Mar 18;60(3):496. doi: 10.3390/medicina60030496.
Both scleroderma and immunoglobulin G4-related disease (IgG4-RD) are systemic fibro-inflammatory diseases characterised by lymphoplasmacytic infiltrates. IgG4-RD and systemic sclerosis (SSc) may share common pathophysiological mechanisms, but no examples of co-occurrence of the diseases have been found. Autologous haematopoietic stem cell transplantation (AHSCT) is implemented in selected rapidly progressive SSc with a high risk of organ failure. However, existing guidelines are based on clinical trials that do not represent the entire patient population and exclude critically ill patients with no therapeutic alternatives. Examples of AHSCT in IgG4-RD are absent. We report the case of a 44-year-old female patient with overlapping progressive diffuse SSc and sinonasal IgG4-RD. After 11 years of ineffective SSc treatment, AHSCT was performed. The 63-month follow-up showed a regression of SSc symptoms. AHSCT was not intended as treatment in the case of IgG4RD, although the first symptoms of the disease developed before transplantation. The sinus lesions progressed after AHSCT and remained indolent only after surgical treatment (bilateral ethmoidectomy, sphenoidotomy, intranasal buccal antrostomy), which allowed histopathological confirmation of IgG4-RD.
硬皮病和免疫球蛋白 G4 相关疾病(IgG4-RD)均为系统性纤维炎症性疾病,其特征为淋巴浆细胞浸润。IgG4-RD 和系统性硬化症(SSc)可能具有共同的病理生理机制,但尚未发现这两种疾病同时发生的病例。自体造血干细胞移植(AHSCT)应用于某些快速进展、有器官衰竭高风险的 SSc 患者。然而,现有的指南是基于临床试验制定的,这些临床试验并不能代表所有患者人群,也排除了没有治疗选择的重症患者。IgG4-RD 中没有 AHSCT 的应用实例。我们报告了一例 44 岁女性患者,患有重叠进行性弥漫性 SSc 和鼻旁窦 IgG4-RD。在 SSc 治疗无效 11 年后,进行了 AHSCT。63 个月的随访显示 SSc 症状消退。尽管 IgG4RD 的最初症状出现在移植之前,但 AHSCT 并非该病的治疗目的。AHSCT 后鼻窦病变进展,仅在手术治疗(双侧筛窦切除术、蝶窦切开术、鼻腔颊窦造口术)后仍为惰性,这允许进行 IgG4-RD 的组织病理学确认。